These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency. Bork K; Bernstein JA; Machnig T; Craig TJ J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769 [TBL] [Abstract][Full Text] [Related]
7. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Bygum A; Andersen KE; Mikkelsen CS Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579 [TBL] [Abstract][Full Text] [Related]
8. Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema. Petraroli A; Squeglia V; Di Paola N; Barbarino A; Bova M; Spanò R; Marone G; Triggiani M Int Arch Allergy Immunol; 2015; 166(4):259-66. PubMed ID: 25924832 [TBL] [Abstract][Full Text] [Related]
9. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Riedl M Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830 [TBL] [Abstract][Full Text] [Related]
11. An analysis of the teaching of intravenous self-administration in patients with hereditary angio-oedema. Mühlberg H; Ettl N; Magerl M Clin Exp Dermatol; 2016 Jun; 41(4):366-71. PubMed ID: 26850568 [TBL] [Abstract][Full Text] [Related]
12. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY]. Fukunaga A; Morita E; Miyagi T; Eto K; Shimizu A; Kagami S; Yamamoto H; Vardi M; Tang Y; Wang Y; Hide M Arerugi; 2020; 69(3):192-203. PubMed ID: 32435020 [TBL] [Abstract][Full Text] [Related]
13. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks. Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635 [TBL] [Abstract][Full Text] [Related]
17. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study. Zanichelli A; Azin GM; Cristina F; Vacchini R; Caballero T Orphanet J Rare Dis; 2018 Apr; 13(1):51. PubMed ID: 29631595 [TBL] [Abstract][Full Text] [Related]